The daily business briefing: July 21, 2023
FTX sues to recover money allegedly pilfered by Bankman-Fried and other former executives, NFL owners approve Commanders' sale, and more
1. FTX sues to recover money from Bankman-Fried, other former executives
FTX lawyers on Thursday filed a lawsuit in Delaware bankruptcy court accusing company co-founder Sam Bankman-Fried and three members of his leadership team of stealing more than $1 billion shortly before the failed cryptocurrency exchange collapsed last year. The lawyers are trying to recover the allegedly misappropriated funds from the former executives and FTX's trading arm, Alameda Research. The suit claims Bankman-Fried took $10 million he is now using to pay his criminal defense bills by routing it through his Morgan Stanley and TD Ameritrade accounts as a gift to his father, legal scholar Joe Bankman. Caroline Ellison, one of the other executives named in the suit, allegedly paid herself a $22.5 million bonus later used to invest in an artificial intelligence company.
2. NFL team owners approve Washington Commanders sale
NFL team owners on Thursday unanimously approved Josh Harris' $6.05 billion purchase of the Washington Commanders from Daniel Snyder. The record-setting sale could close as soon as Friday. The deal sets up the first change in ownership for the pro football team since Snyder bought it for $800 million from the Jack Kent Cooke estate in 1999. Snyder owned the team for 24 years but never restored the success it had on the field under Cooke's ownership. As part of the sale process, Snyder will pay the NFL $60 million as a result of a league investigation that found he sexually harassed an employee and the Commanders kept some revenue they should have shared with other teams.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Google tests AI journalism tool
Google is testing an artificial-intelligence tool that can use details on current events to produce news stories, according to The New York Times. The company has demonstrated the product, currently called Genesis, to the Times, The Washington Post, and News Corp, which owns The Wall Street Journal. Google co-founder Sergey Brin has returned to Google's Mountain View, California, offices for several days a week in recent month to work with researchers developing the tech giant's next major AI initiative, the Journal reported Thursday. His presence marks a change from the "hands-off approach he adopted after stepping down from an executive role" in 2019, the Journal says.
The New York Times The Wall Street Journal
4. Stock futures rise after Dow extends winning streak
U.S. stock futures rose early Friday after the Dow Jones Industrial Average on Thursday rose for the ninth straight day, its longest winning streak since 2017. Futures tied to the Dow and the S&P 500 were up 0.1% and 0.3%, respectively, at 7 a.m. ET. Nasdaq futures were up 0.5%. Transportation stocks CSX and Knight-Swift fell sharply in pre-market trading after they reported quarterly results that fell short of Wall Street expectations. The Dow gained 0.5% on Thursday but the S&P 500 and the tech-heavy Nasdaq fell 0.7% and 2.1%, respectively, as investors reacted to mixed earnings reports, although 73% of the S&P 500 companies that have reported second-quarter earnings so far have beaten analysts' expectations, according to FactSet.
5. Tornado damage at Pfizer plant could worsen shortages of some drugs
A tornado that damaged a North Carolina Pfizer factory this week could further strain U.S. drug supplies at hospitals, The Associated Press reported Thursday, citing health care industry experts. The tornado tore up the roof of the factory, which makes nearly a quarter of Pfizer's sterile injectable medicines used in U.S. hospitals, the drugmaker said. The plant makes drugs for anesthesia, infection treatment, and use in surgeries and intensive care units for patients on ventilators. The massive plant has 22 packaging lines and 1.4 million square feet of manufacturing space. The damage could result in shortages of some drugs as Pfizer rebuilds or shifts production elsewhere, Erin Fox, senior pharmacy director at University of Utah Health, told AP.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
The daily business briefing: January 24, 2024
Business Briefing The S&P 500 sets a third straight record, Netflix adds more subscribers than expected, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 23, 2024
Business Briefing The Dow and S&P 500 set fresh records, Bitcoin falls as ETF enthusiasm fades, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 22, 2024
Business Briefing FAA recommends inspections of a second Boeing 737 model, Macy's rejects Arkhouse bid, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 19, 2024
Business Briefing Macy's to cut 2,350 jobs, Congress averts a government shutdown, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 18, 2024
Business Briefing Shell suspends shipments in the Red Sea, December retail sales beat expectations, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 17, 2024
Business Briefing Judge blocks JetBlue-Spirit merger plan, Goldman Sachs beats expectations with wealth-management boost, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 16, 2024
Business Briefing Boeing steps up inspections on 737 Max 9 jets, Zelenskyy fights for world leaders' attention at Davos, and more
By Harold Maass, The Week US Published
-
The daily business briefing: January 12, 2024
Business Briefing Inflation was slightly hotter than expected in December, Hertz is selling a third of its EVs to buy more gas cars, and more
By Harold Maass, The Week US Published